Procept Biorobotics Corp (PRCT) Stock Analysis

Procept Biorobotics Corp (PRCT) is a publicly traded company in the HEALTHCARE sector. It trades at $26.76, carries a market capitalization of $1.59B. This page summarizes the public market data, fundamentals, and frequently asked questions for PRCT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $26.76
• Market Cap: $1.59B
• EPS: $-1.83
• 52-Week High: $66.85
• 52-Week Low: $19.35

Market Sentiment

Procept Biorobotics Corp currently has a Bullish sentiment score of 0.34.

About Procept Biorobotics Corp

PROCEPT BioRobotics Corporation (Ticker: PRCT) is a leading surgical robotics company headquartered in Redwood City, California, specializing in cutting-edge solutions for urological surgeries. Its flagship robotic-assisted systems significantly enhance the precision and efficacy of surgical interventions, contributing to improved patient outcomes and optimized operational efficiencies. Committed to advancing the field of urology through innovative technologies, PROCEPT is focused on addressi...

GNG Research Analysis

GNG Research scores Procept Biorobotics Corp (PRCT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PRCT.

Frequently Asked Questions

Does PRCT pay dividends?

Procept Biorobotics Corp (PRCT) does not currently pay a regular dividend.

What is PRCT's market cap?

Procept Biorobotics Corp (PRCT) has a market capitalization of $1.59B with a current stock price of $26.76.